Male and Female Stem Cells Derived from One Donor in Scientific First
By Dan Robitzski,
The Scientist
| 12. 22. 2022
Scientists have developed a new line of stem cells—all derived from the same person—that can be used to study sex differences without the confounds of interpersonal genetic differences.
Human induced pluripotent stem cells (hiPSCs), which are cells taken from a person that are then reprogrammed to abandon their current roles and return to a stem cell–like state, have become valuable tools not only for therapeutic purposes but also for probing the genetic mechanisms underlying cell behavior and disease. However, findings drawn from stem cell studies may not be broadly applicable, as the fact that all cells in a given line share the same genetic sequence makes it difficult to generalize discoveries, especially when it comes to investigating potential sex differences.
That’s why a team of scientists led by Benjamin Reubinoff, an embryonic stem cell researcher at the Hadassah Medical Organization in Jerusalem, and MD-PhD student Ithai Waldhorn set out to create a new platform for studying genetic sex differences. As Reubinoff tells The Scientist, “The origin was really to generate a model for studying sex differences, given the...
Related Articles
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...
Faster, Higher, Stronger was the Olympic motto from 1874 until 2001, when “ – Together” was added, to stress the “moral and educational perspective” of the Games. The folks who paid for or participated in the Enhanced Games – the name itself a nod to the Olympics – held in Las Vegas on Sunday, May 24, apparently use a different edit:
Faster, Higher, Stronger with Chemistry
High-level sport draws huge crowds. Coming very soon, the soccer World Cup, featuring...
By Gina Kolata, The New York Times | 05.25.2026
In a small, preliminary study, an experimental gene-editing treatment dramatically lowered cholesterol levels, perhaps permanently, after just one infusion, scientists reported on Monday.
If confirmed in larger studies, researchers hope the findings may lead to a one-and-done way to prevent...
By Ryan Cross, Endpoint News | 05.20.2026
BOSTON — Over the past year, I’ve begun hearing rumblings from scientists who secretly think it’s time to stop being stodgy about editing the genes of human embryos.
For the most part, they are still too timid to speak up...
